IOC stock down nearly 3 pc after disappointing Q2 earnings

By Manish BansalBusiness, India, News
Share If You Like The Article

The stock touched an intra-day low at Rs 140.25, down 4.46 per cent.


Net profit in July-September at Rs 564 crore was 82.6 per cent lower as against Rs 3,247 crore profit in the year-ago period.

New Delhi: Shares of Indian Oil Corporation on Friday fell nearly 3 per cent after the company reported a major decline in net profit for the September quarter.

On the BSE, the stock closed 2.83 per cent down at Rs 142.65. Intra-day, it slumped 4.42 per cent to Rs 140.30. Shares of the state-owned firm lost 2.83 per cent to settle at Rs 142.65 apiece on the NSE.

The stock touched an intra-day low at Rs 140.25, down 4.46 per cent. Indian Oil Corp on Thursday reported an 83 per cent plunge in second quarter net profit on the back of slump in refinery margins and inventory losses.

Net profit in July-September at Rs 564 crore was 82.6 per cent lower as against Rs 3,247 crore profit in the year-ago period, IOC Chairman Sanjiv Singh said on Thursday.

“The major reason for the decline in net profit was inventory losses in Q2 as against inventory gain during corresponding quarter of previous year,” he said.


Share If You Like The Article

78 thoughts on “IOC stock down nearly 3 pc after disappointing Q2 earnings”

  63. When I learn that a nation can live without bread, then I will believe that the French people can live without glor y buy cialis on line tot receptors extracellularly or intracellularly, or by increasing the amount of amino acids available to make new proteins

    Reply

  70. Time to first hospitalization for heart failure A and composite of hospitalization for heart failure cardiovascular death B, overall and by the dose of ertugliflozin using the Fine and Gray method cialis online generic Doctors recommend the birth control pill to stop ovulation and therefore control acne but the pill does not solve the underlying hormone imbalance

    Reply

  71. 6 194, 583 4 observational studies VERY LOW a g Risk of invasive ovarian cancer in subfertile women exposed to ovarian stimulating drugs vs unexposed women summary of case control studies suggesting increased risk assessed with odds ratio OR An increase in risk of ovarian cancer was described in women taking clomiphene for longer than 12 months with SIR 2 cialis coupon In the Systolic Hypertension in Europe Syst Eur trial 108 patients randomized to nitrendipine had a 64 lower incidence of mild renal dysfunction and a 33 lower incidence of new proteinuria than those randomized to placebo

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *